BR9917152A - Composição para tratamento terapêutico ou profilático de infecção estreptocócica e método e uso respectivos - Google Patents

Composição para tratamento terapêutico ou profilático de infecção estreptocócica e método e uso respectivos

Info

Publication number
BR9917152A
BR9917152A BR9917152-0A BR9917152A BR9917152A BR 9917152 A BR9917152 A BR 9917152A BR 9917152 A BR9917152 A BR 9917152A BR 9917152 A BR9917152 A BR 9917152A
Authority
BR
Brazil
Prior art keywords
therapeutic
composition
prophylactic treatment
respective method
streptococcal infection
Prior art date
Application number
BR9917152-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Vincent Fischetti
Lawrence Loomis
Original Assignee
New Horizons Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Horizons Diagnostics Inc filed Critical New Horizons Diagnostics Inc
Publication of BR9917152A publication Critical patent/BR9917152A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9917152-0A 1999-02-25 1999-02-25 Composição para tratamento terapêutico ou profilático de infecção estreptocócica e método e uso respectivos BR9917152A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1999/004063 WO2000050069A1 (en) 1999-02-25 1999-02-25 A means for the prophylactic and therapeutic treatment of streptococcal infections
US09/257,025 US6017528A (en) 1997-10-31 1999-02-25 Therapeutic treatment of group A streptococcal infections

Publications (1)

Publication Number Publication Date
BR9917152A true BR9917152A (pt) 2002-11-26

Family

ID=26795447

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9917152-0A BR9917152A (pt) 1999-02-25 1999-02-25 Composição para tratamento terapêutico ou profilático de infecção estreptocócica e método e uso respectivos

Country Status (12)

Country Link
US (1) US6017528A (enExample)
EP (1) EP1162994A4 (enExample)
JP (1) JP2002537350A (enExample)
KR (1) KR20020000217A (enExample)
AU (1) AU2876799A (enExample)
BR (1) BR9917152A (enExample)
CA (1) CA2366712A1 (enExample)
HK (1) HK1047243A1 (enExample)
IN (1) IN2001DE00791A (enExample)
MX (1) MXPA01008701A (enExample)
NZ (1) NZ514260A (enExample)
WO (1) WO2000050069A1 (enExample)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7232576B2 (en) 1997-10-31 2007-06-19 New Horizons Diagnostics Corp Throat lozenge for the treatment of Streptococcus Group A
US6277399B1 (en) 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6432444B1 (en) * 1997-10-31 2002-08-13 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymes for treating dermatological infections
US6428784B1 (en) * 1997-10-31 2002-08-06 New Horizons Diagnostics Corp Vaginal suppository for treating group B Streptococcus infection
US6335012B1 (en) 1997-10-31 2002-01-01 Vincent Fischetti Use of bacterial phage associated lysing enzymes for treating bacterial infections of the mouth and teeth
US6399097B1 (en) 1997-10-31 2002-06-04 New Horizons Diagnostics Corporation Composition for treatment of a bacterial infection of the digestive tract
US20030129147A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
US20020136712A1 (en) * 1997-10-31 2002-09-26 Fischetti Vincent Bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of colonization and infections caused by streptococcus pneumoniae
US20030129146A1 (en) * 1997-10-31 2003-07-10 Vincent Fischetti The use of bacterial phage associated lysing proteins for treating bacterial dental caries
US6423299B1 (en) 1997-10-31 2002-07-23 Vincent Fischetti Composition for treatment of a bacterial infection of an upper respiratory tract
US6056954A (en) * 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US6399098B1 (en) 1997-10-31 2002-06-04 New Horizons Diagnostics Corp Composition for treating dental caries caused by streptococcus mutans
US20030082110A1 (en) * 1997-10-31 2003-05-01 Vincent Fischetti Use of bacterial phage associated lysing proteins for treating bacterial dental caries
US6248324B1 (en) 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US6752988B1 (en) * 2000-04-28 2004-06-22 New Horizons Diagnostic Corp Method of treating upper resiratory illnesses
US6406692B1 (en) * 1997-10-31 2002-06-18 New Horizons Diagnostics Corp Composition for treatment of an ocular bacterial infection
US6326002B1 (en) 1997-10-31 2001-12-04 New Horizons Diagnostics Corporation Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract
US7063837B2 (en) * 1999-09-14 2006-06-20 New Horizons Diagnostics Corp Syrup composition containing phage associated lytic enzymes
US20020127215A1 (en) * 1999-09-14 2002-09-12 Lawrence Loomis Parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
AU2001259205A1 (en) * 2000-04-28 2001-11-12 New Horizons Diagnostic Corporation The use of bacterial phage associated lysing enzymes for treating various illnesses
AU2001263408A1 (en) 2000-05-23 2001-12-03 The Rockefeller University C1 bacteriophage lytic system
US6395504B1 (en) 2000-09-01 2002-05-28 New Horizons Diagnostics Corp. Use of phage associated lytic enzymes for the rapid detection of bacterial contaminants
CA2427928A1 (en) * 2000-11-02 2002-12-27 New Horizons Diagnostics Corporation The use of bacterial phage associated lytic enzymes to prevent food poisoning
US20040213765A1 (en) * 2001-07-13 2004-10-28 Vincent Fischetti Use of bacterial phage associated lytic enzymes to prevent food poisoning
GB0118009D0 (en) * 2001-07-24 2001-09-19 Regma Biotechnologies Ltd Novel preparation
US6759229B2 (en) * 2001-12-18 2004-07-06 President & Fellows Of Harvard College Toxin-phage bacteriocide antibiotic and uses thereof
WO2004020451A1 (en) * 2002-08-29 2004-03-11 The Uab Research Foundation Group b streptococcal phage lysin
US7569223B2 (en) * 2004-03-22 2009-08-04 The Rockefeller University Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions
CA2833409A1 (en) 2011-04-21 2012-10-26 The Rockefeller University Streptococcus bacteriophage lysins for detection and treatment of gram positive bacteria
DK3369742T3 (da) 2011-10-05 2020-10-19 Univ Rockefeller Dimere bakteriofaglysiner
JP6608697B2 (ja) 2012-05-09 2019-11-20 コントラフェクト コーポレイション グラム陽性菌に対するバクテリオファージ溶解素と抗生物質との組み合わせ
RU2646102C2 (ru) 2012-05-09 2018-03-01 Контрафект Корпорейшн Предотвращение, разрушение и обработка биопленки лизином бактериофага
KR101723466B1 (ko) 2015-10-08 2017-04-06 주식회사 인트론바이오테크놀로지 신규한 스트렙토코커스 이니에 박테리오파지 Ｓｔｒ-ＩＮＰ-1 및 이의 스트렙토코커스 이니에 균 증식 억제 용도
DK3454888T3 (da) 2016-05-12 2021-04-26 Contrafect Corp Bouillon-mikrofortyndingsfremgangsmåde til evaluering og bestemmelse af minimal inhibitorisk koncentration for antibakterielle polypeptider
WO2018011660A1 (en) 2016-07-11 2018-01-18 Philip Morris Products S.A. Hydrophobic capsule
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852424A (en) * 1957-07-26 1974-12-03 Ciba Geigy Corp Purified ferrimycin and process for obtaining same
AU8108587A (en) * 1986-10-08 1988-05-06 David Bernstein Method for exposing group a streptococcal antigens and an improved diagnostic test for the identification of group a streptococci
US5997862A (en) * 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections

Also Published As

Publication number Publication date
JP2002537350A (ja) 2002-11-05
HK1047243A1 (zh) 2003-02-14
CA2366712A1 (en) 2000-08-31
NZ514260A (en) 2003-02-28
WO2000050069A1 (en) 2000-08-31
IN2001DE00791A (enExample) 2007-05-25
US6017528A (en) 2000-01-25
MXPA01008701A (es) 2003-06-24
EP1162994A4 (en) 2004-12-29
KR20020000217A (ko) 2002-01-05
EP1162994A1 (en) 2001-12-19
AU2876799A (en) 2000-09-14

Similar Documents

Publication Publication Date Title
BR9917152A (pt) Composição para tratamento terapêutico ou profilático de infecção estreptocócica e método e uso respectivos
MXPA02002895A (es) Tratamiento topico de infecciones por estreptococcus.
ATE421883T1 (de) Beta-glucan enthaltende zusammenstellungen und spezifische immunoglobuline
BRPI9908182C1 (pt) composições de proteína de matriz para cura de feridas
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
HUP0002322A2 (hu) Multivalens vakcinakészítmény kevert hordozóval
BR9710768A (pt) Composto composi-Æo e processos para tratamento de infec-{es bacterianas em um mamifero hospedeiro com necessidade de tal tratamento e para prepara-Æo de 6-0-metileritromicina forma i
BR0210941A (pt) Terapia de combinação de oxazolidinonas substituìdas
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
UA85993C2 (ru) Конъюгат, который содержит бактериальный суперантиген и антительную составную, фармацевтическая композиция, которая его содержит, и способ лечения рака у млекопитающего
PT806941E (pt) Composicoes anti-bacterianas liposomicas de rigidez baixa
DK1059934T3 (da) Matrixproteinpræparater til sårheling
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
AU2003241345A1 (en) Use of mastic and its components for the control of microbial infections
ATE355288T1 (de) Verbindungen und therapeutische methoden
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
EP0932613A4 (en) EXPRESSION BLOCKING OF VIRULENT FACTORS IN S. AUREUS
DE60138572D1 (de) Methoden und pharmazeutische zusammensetzungen zur wundheilung
DK227090D0 (da) Organisk guldkompleks til topisk anvendelse
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
ATE405276T1 (de) Pharmazeutische gel-zusammensetzung
BR9714945A (pt) Composição topicamente aplicável para introdução de fármacos peptidaceosos em organismos vivos
BR0014751A (pt) Composto, estereoisÈmero ou mistura de estereoisÈmeros, composição farmacêutica, método de tratamento de um paciente em necessidade de tratamento antimicrobiano, e, uso de um composto

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 8A., 9A. E 10A. ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DE RPI 1999 DE 28/04/2009.